Morning Market Movers By: Benzinga via Benzinga April 22, 2014 at 09:43 AM EDT Revance Therapeutics (NASDAQ: RVNC) shares gained 21.91% to $34.89 after the company reported positive results from the RT002 Phase 1/2 ... Read More >> Related Stocks: Axogen Inc Centene Corp Evoke Pharma Harley-Davidson Intricon Corp Intuitive Surgical Netflix Rent-A-Center Inc Revance Therapeutics Valeant Pharmaceuticals International, Inc.